Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.
The role of tumor stem cells in benign tumors such as pituitary adenomas remains unclear. In this study, we investigated whether the cells within pituitary adenomas that spontaneously develop in Rb+/- mice are hierarchically distributed with a subset being responsible for tumor growth. Cells derived directly from such tumors grew as spheres in serum-free culture medium supplemented with epidermal growth factor and basic fibroblast growth factor. Some cells within growing pituitary tumor spheres (PTS) expressed common stem cell markers (Sca1, Sox2, Nestin, and CD133), but were devoid of hormone-positive differentiated cells. Under subsequent differentiating conditions (matrigel-coated growth surface), PTS expressed all six pituitary hormones. We next searched for specific markers of the stem cell population and isolated a Sca1(+) cell population that showed increased sphere formation potential, lower mRNA hormone expression, higher expression of stem cell markers (Notch1, Sox2, and Nestin), and increased proliferation rates. When transplanted into non-obese diabetic-severe combined immunodeficiency gamma mice brains, Sca1(+) pituitary tumor cells exhibited higher rates of tumor formation (brain tumors observed in 11/11 (100%) vs 7/12 (54%) of mice transplanted with Sca1(+) and Sca1(-) cells respectively). Magnetic resonance imaging and histological analysis of brain tumors showed that tumors derived from Sca1(+) pituitary tumor cells were also larger and plurihormonal. Our findings show that Sca1(+) cells derived from benign pituitary tumors exhibit an undifferentiated expression profile and tumor-proliferative advantages, and we propose that they could represent putative pituitary tumor stem/progenitor cells.
Pituitary Center, Cedars-Sinai Medical Center, Regenerative Medicine Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, California 90048, USA.
Ines
I
Donangelo
Song-Guang
SG
Ren
Tamar
T
Eigler
Clive
C
Svendsen
Shlomo
S
Melmed
D000236:Adenoma / Q000378:metabolism* / Q000473:pathology*; D000818:Animals; D000950:Antigens, Ly / Q000378:metabolism*; D002454:Cell Differentiation; D049109:Cell Proliferation; D005260:Female; D008565:Membrane Proteins / Q000378:metabolism*; D051379:Mice; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000473:pathology*; D047368:Tumor Burden; D014407:Tumor Cells, Cultured
D000950:Antigens, Ly; C074650:Ly6a protein, mouse; D008565:Membrane Proteins
neoplasia; pathogenesis; pituitary